Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pharmion Corp (PHRM) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Pharmion Corp. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1203866.
Total stock buying since 2005: $21,312,958.
Total stock sales since 2005: $4,875,933.
Total stock option exercises since 2005: $3,312,225.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 0 | $0 | 0 | $0 | 132,443 | $2,332,795 |
| 2007 | 0 | $0 | 83,840 | $3,445,437 | 101,100 | $979,430 |
| 2006 | 1,103,913 | $20,926,368 | 21,666 | $366,112 | 0 | $0 |
| 2005 | 22,000 | $386,590 | 57,650 | $1,064,384 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-03 | 0 | $0 | 0 | $0 | 132,443 | $2,332,795 |
| 2007-12 | 0 | $0 | 0 | $0 | 7,037 | $450,001 |
| 2007-11 | 0 | $0 | 0 | $0 | 32,813 | $193,268 |
| 2007-09 | 0 | $0 | 0 | $0 | 1,250 | $51,262 |
| 2007-08 | 0 | $0 | 83,840 | $3,445,437 | 60,000 | $284,899 |
| 2006-08 | 1,300 | $22,867 | 0 | $0 | 0 | $0 |
| 2006-06 | 46,300 | $818,414 | 0 | $0 | 0 | $0 |
| 2006-05 | 1,012,000 | $19,332,599 | 0 | $0 | 0 | $0 |
| 2006-03 | 42,813 | $729,238 | 21,666 | $366,112 | 0 | $0 |
| 2006-02 | 1,500 | $23,250 | 0 | $0 | 0 | $0 |
| 2005-12 | 0 | $0 | 7,650 | $141,035 | 0 | $0 |
| 2005-11 | 0 | $0 | 50,000 | $923,349 | 0 | $0 |
| 2005-10 | 22,000 | $386,590 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-03-07 | Allen Andrew R (Chief Medical Officer, EVP) | Option Ex | 3,800 | 72.49 | 275,462 |
| 2008-03-07 | Dupont Steven N (EVP and General Counsel) | Option Ex | 1,650 | 72.49 | 119,608 |
| 2008-03-07 | Cosgrave Michael (EVP, Global Commercial) | Option Ex | 3,750 | 72.49 | 271,837 |
| 2008-03-07 | Ivers-read Gillian C (EVP, Development Operations) | Option Ex | 2,100 | 72.49 | 152,229 |
| 2008-03-07 | Mahaffy Patrick J (CEO, President) | Option Ex | 9,375 | 72.49 | 679,593 |
| 2008-03-07 | Mast Erle T (EVP, CFO) | Option Ex | 2,625 | 72.49 | 190,286 |
| 2008-03-04 | Mahaffy Patrick J (CEO, President) | Option Ex | 46,330 | 11.25 | 521,351 |
| 2008-03-03 | Mast Erle T (EVP, CFO) | Option Ex | 62,500 | 1.60 | 100,000 |
| 2008-03-01 | Allen Andrew R (Chief Medical Officer, EVP) | Option Ex | 313 | 71.66 | 22,429 |
| 2007-12-06 | Allen Andrew R (Chief Medical Officer, EVP) | Option Ex | 225 | 63.98 | 14,395 |
| 2007-12-06 | Dupont Steven N (Executive VP, General Counsel) | Option Ex | 550 | 63.98 | 35,189 |
| 2007-12-06 | Cosgrave Michael (EVP, Global Commercial) | Option Ex | 1,250 | 63.98 | 79,975 |
| 2007-12-06 | Ivers-read Gillian C (EVP, Development Operations) | Option Ex | 700 | 63.98 | 44,786 |
| 2007-12-06 | Mahaffy Patrick J (CEO, President) | Option Ex | 3,125 | 63.98 | 199,937 |
| 2007-12-06 | Mast Erle T (EVP, CFO) | Option Ex | 875 | 63.98 | 55,982 |
| 2007-12-01 | Allen Andrew R (Chief Medical Officer, EVP) | Option Ex | 312 | 63.26 | 19,737 |
| 2007-11-08 | Ivers-read Gillian C (EVP, Development Operations) | Option Ex | 32,813 | 5.89 | 193,268 |
| 2007-09-01 | Allen Andrew R (Chief Medical Officer, EVP) | Option Ex | 1,250 | 41.01 | 51,262 |
| 2007-08-24 | Ivers-read Gillian C (EVP, Development Operations) | Sale | 23,840 | 38.53 | 918,507 |
| 2007-08-06 | Dupont Steven N (VP, General Counsel) | Sale | 10,000 | 42.69 | 426,930 |
| 2007-08-06 | Dupont Steven N (VP, General Counsel) | Option Ex | 10,000 | 18.49 | 184,899 |
| 2007-08-06 | Mast Erle T (EVP, CFO) | Sale | 50,000 | 42.00 | 2,100,000 |
| 2007-08-06 | Mast Erle T (EVP, CFO) | Option Ex | 50,000 | 2.00 | 100,000 |
| 2006-08-06 | Mckinley Edward J (Director) | Buy | 1,300 | 17.59 | 22,867 |
| 2006-06-09 | Blair James C (Director) | Buy | 31,600 | 17.71 | 559,636 |
| 2006-06-08 | Mckinley Edward J (Director) | Buy | 14,700 | 17.60 | 258,778 |
| 2006-05-04 | Blair James C (Director) | Buy | 285,200 | 19.98 | 5,698,296 |
| 2006-05-03 | Blair James C (Director) | Buy | 500,000 | 18.64 | 9,320,000 |
| 2006-05-02 | Blair James C (Director) | Buy | 103,000 | 19.01 | 1,958,030 |
| 2006-05-01 | Mckinley Edward J (Director) | Buy | 12,000 | 19.06 | 228,719 |
| 2006-05-01 | Blair James C (Director) | Buy | 111,800 | 19.03 | 2,127,554 |
| 2006-03-03 | Mckinley Edward J (Director) | Buy | 34,000 | 17.11 | 578,726 |
| 2006-03-03 | Hemberger Judith A (Exec VP and COO) | Sale | 21,666 | 16.90 | 366,112 |
| 2006-03-02 | Mahaffy Patrick J (President and CEO) | Buy | 5,882 | 17.01 | 100,052 |
| 2006-02-24 | Mast Erle T (Executive VP and CFO) | Buy | 1,500 | 15.50 | 23,250 |
| 2005-12-13 | Ivers-read Gillian C (Vice President) | Sale | 7,650 | 18.44 | 141,035 |
| 2005-11-01 | Hemberger Judith A (Exec VP and COO) | Sale | 50,000 | 18.47 | 923,349 |
| 2005-10-28 | Mckinley Edward J (Director) | Buy | 20,000 | 17.57 | 351,420 |
| 2005-10-28 | Mast Erle T (Chief Financial Officer) | Buy | 2,000 | 17.59 | 35,170 |
Insider trading activities including stock purchases, stock sales, and option exercises of PHRM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pharmion Corp (symbol PHRM, CIK number 1203866) see the Securities and Exchange Commission (SEC) website.